Showing results (71-80 of 144) with videos related to
Sort By:
Pageof 15
Bioorganic & Medicinal Chemistry Letters|November 23, 2019
In vivo comparison of N-11CH3 vs O-11CH3 radiolabeled microtubule targeted PET ligandsJ S Dileep Kumar, Jaya Prabhakaran, Naresh Damuka, et al.European Journal of Nuclear Medicine and Molecular Imaging|November 9, 2022
Preliminary efficacy of [90Y]DOTA-biotin-avidin radiotherapy against non-muscle invasive bladder cancerAlessandra Alì, Dev Leibowitz, Nikunj Bhatt, et al.Journal of Medicinal Chemistry|February 20, 2018
Radiosynthesis and in Vivo Evaluation of [11C]MPC-6827, the First Brain Penetrant Microtubule PET LigandJ S Dileep Kumar, Kiran Kumar Solingapuram Sai, Jaya Prabhakaran, et al.The International Journal of Biochemistry & Cell Biology|April 9, 2018
Perivascular cell αv integrins as a target to treat skeletal muscle fibrosisPedro H D M Prazeres, Anaelise O M Turquetti, Patrick O Azevedo, et al.Oncotarget|September 9, 2017
Peptide-based PET imaging of the tumor restricted IL13RA2 biomarkerKiran Kumar Solingapuram Sai, Anirudh Sattiraju, Frankis G Almaguel, et al.Neurology|March 18, 2018
Arterial stiffness and dementia pathology: Atherosclerosis Risk in Communities (ARIC)-PET StudyTimothy M Hughes, Lynne E Wagenknecht, Suzanne Craft, et al.ACS Chemical Neuroscience|May 10, 2017
Radiosynthesis and in Vivo Evaluation of [11C]A1070722, a High Affinity GSK-3 PET Tracer in Primate BrainJaya Prabhakaran, Francesca Zanderigo, Kiran Kumar Solingapuram Sai, et al.Cancer Metastasis Reviews|September 12, 2018
Cross-talk between lung cancer and bones results in neutrophils that promote tumor progressionPatrick O Azevedo, Ana E Paiva, Gabryella S P Santos, et al.Cancers|October 14, 2022
Evaluating the Combined Anticancer Response of Checkpoint Inhibitor Immunotherapy and FAP-Targeted Molecular Radiotherapy in Murine Models of Melanoma and Lung CancerKathleen M Capaccione, Mikhail Doubrovin, Brian Braumuller, et al.Cancer Medicine|February 27, 2018
Glioblastoma-activated pericytes support tumor growth via immunosuppressionIsadora F G Sena, Ana E Paiva, Pedro H D M Prazeres, et al.Pageof 15